Presence of atopy increases the risk of asthma relapse

Laurel Teoh1,2, Ian M Mackay3,4, Peter P Van Asperen5,6

  • 1Department of Paediatrics and Child Health, Centenary Hospital for Women and Children, Canberra, Australian Capital Territory, Australia.

Insights

Respiratory viruses are common in childhood asthma exacerbations but do not affect recovery. Atopy, however, is linked to asthma relapse in children, while atypical bacteria are rare triggers.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Allergy and Immunology

Background:

  • Acute asthma exacerbations in children are frequently associated with respiratory infections.
  • The role of specific respiratory viruses and atypical bacteria in asthma severity and recovery remains incompletely understood.
  • Atopy is a known risk factor for asthma, but its specific impact on exacerbation recovery needs further clarification.

Purpose of the Study:

  • To determine the prevalence of respiratory viruses and atypical bacteria in children with asthma exacerbations using PCR.
  • To assess the influence of these pathogens and atopy on the acute severity and clinical recovery of childhood asthma.
  • To investigate the association between specific pathogens, atopy, and asthma relapse.

Main Methods:

  • Prospective study conducted in hospital emergency departments from 2009-2011.
  • Recruited 244 children (aged 2-16 years) presenting with acute asthma.
  • Utilized PCR for pathogen detection, nasopharyngeal aspirates, allergen skin prick tests, and validated outcome measures for severity and recovery.

Main Results:

  • Respiratory viruses were detected in 81.7% of children, with human rhinovirus being the most common (75.1%).
  • Atypical bacteria like *Mycoplasma pneumoniae* and *Chlamydophila pneumoniae* were rarely identified.
  • Pathogen presence had minimal impact on acute asthma severity or recovery, whereas atopy significantly increased the likelihood of relapse (OR 1.11).

Conclusions:

  • While viruses are associated with asthma exacerbations, they do not appear to influence recovery.
  • Atopy is a significant factor associated with asthma relapse in children.
  • *Mycoplasma pneumoniae* and *Chlamydophila pneumoniae* are uncommon causes of acute asthma exacerbations in this pediatric population.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K